Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189

Rodriguez-Abreu, D; Powell, SF; Hochmair, MJ; Gadgeel, S; Esteban, E; Felip, E; Speranza, G; De Angelis, F; Domine, M; Cheng, SY; Bischoff, HG; Peled, N; Reck, M; Hui, R; Garon, EB; Boyer, M; Kurata, T; Yang, J; Pietanza, MC; Souza, F; Garassino, MC

Rodriguez-Abreu, D (corresponding author), Univ Palmas Gran Canaria, Complejo Hosp Univ Insular Materno Infantil Gran, Med Oncol, Ave Maritima Sur S-N, Las Palmas Gran Canaria 35016, Spain.

ANNALS OF ONCOLOGY, 2021; 32 (7): 881

Abstract

Background: In the phase III KEYNOTE-189 study (NCT02578680), pembrolizumab plus pemetrexed and platinum-based chemotherapy (pemetrexed-platinum) sign......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索